MISSISSAUGA, ON, May 4, 2021 /CNW/ - Amgen Canada today announced that AMGEVITA ® (adalimumab, reference biologic drug: Humira ®), is now available in Canada for the treatment of 11 chronic ...
Pharmac’s chief medical officer Dr David Hughes has today announced the decision to fund a biosimilar adalimumab (Amgevita), improving access to adalimumab for more than 700 New Zealanders. Adalimumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results